Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial. (2022)

First Author: Gombe B
Attributed to:  Pathogen Genomics, Phenotype and Immunity (PGPI) & Basic Sciences Programme funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0275927

PubMed Identifier: 36327320

Publication URI: http://europepmc.org/abstract/MED/36327320

Type: Journal Article/Review

Volume: 17

Parent Publication: PloS one

Issue: 11

ISSN: 1932-6203